Loading...

BGLC BIONEXUS GENE LAB CORP Capital Structure Changes 8-K Filing

BNXS

BGLC

BIONEXUS GENE LAB CORP

(BGLC)

2025 8-K

Show Summary

Summary

Shareholder Meeting

Strategic Partnership

Ethereum Strategy

Nasdaq Compliance

Delisting Notification

Director Resignations

Annual Meeting Results

Biogas Collaboration

Strategic Agreement

Expansion Plans

Co-Investment Announcement

Strategic Investment

Amendment of Service Contract

Management Changes

Resignation of CFO

Amendment - Disclosure of F...

Appointment of CEO

Resignation of CEO

Management Changes

Equity Offerings

External Links:

BIONEXUS GENE LAB CORP announced a reverse stock split of 1-for-10 approved by shareholders on March 19, 2025, effective April 7, 2025, to comply with NASDAQ bid price requirements.

AI Assistant

BIONEXUS GENE LAB CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.